Codi QR

The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection

Introduction: Dosing recommendations for paliperidone long-acting injectable antipsychotic (LAIA) do not include oral antipsychotic (OAP) overlap; however, OAPs are often given concurrently despite limited evidence describing both the risks and benefits of this practice. Methods: A retrospective cha...

Descripció completa

Guardat en:
Autors principals: Trevor A. Stump, PharmD, BCPP, Leigh Anne Nelson, PharmD, BCPP, Yifei Liu, BS Pharm, PhD, Carrie R. Kriz, MS, Courtney A. Iuppa, PharmD, BCPP, Lauren A. Diefenderfer, PharmD, BCPP, Shelby E. Lang, PharmD, BCPP, Ellie S. R. Elliot, PharmD, BCPP, Roger W. Sommi, PharmD, BCPP, FCCP
Format: Artigo
Idioma:Inglês
Publicat: American Association of Psychiatric Pharmacists 2021-01-01
Col·lecció:Mental Health Clinician
Matèries:
paliperidone palmitate
long-acting injectable antipsychotic
oral antipsychotic overlap
benztropine
adverse events
decompensation
Accés en línia:https://theijpt.org/doi/pdf/10.9740/mhc.2021.01.012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars